BSE filing, NSE: ICICIAMC. Summary written from the filing by ALFA Finder's alert engine.
ICICI Prudential Asset Management Company Ltd: key numbers
- Share price
- ₹2,880.00
- Market cap
- ₹1,42,346 Cr
- Revenue (annual)
- ₹5,999 Cr
- Net profit (annual)
- ₹3,298 Cr
- P/E (TTM)
- 40.3×Sector 19.4×
- Promoter holding
- 85.60%-2.00% QoQ
- FII holding
- 3.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from ICICI Prudential Asset Management Company Ltd
All →ICICI Prudential Asset Management Company Management Change
ICICI Prudential AMC disclosed that Senior Management Personnel Anand Shah resigned, ceasing to be SMP after November 12, 2026. The resignation is a personnel change, with no monetary impact.
ICICI Prudential Asset Management Company Other Announcement
The company filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ended September 30, 2026.
ICICI Prudential Asset Management Company Earnings Call Transcript: Key Takeaways
Operating revenue grew 16.3% YoY to ₹1,674 Cr, though mark-to-market hits on treasury dragged PAT down 7.8% QoQ.
ICICI Prudential Asset Management Company Dividend
ICICI Prudential Asset Management Company declared an interim dividend of ₹30 per equity share for FY 2026-27. The record date is October 21, 2026.
ICICI Prudential Asset Management Company Investor Presentation: Key Takeaways
ICICI Prudential AMC reported strong growth for Q2 FY27, focusing on market share leadership in active and hybrid equity segments while maintaining a 'Customer First' trust compass strategy.
ICICI Prudential Asset Management Company Q2 FY27 Results: Net Profit ₹889 Cr, Up 6.1% YoY
ICICI Prudential Asset Management Company Ltd reported revenue from operations of ₹1,674 Cr (+16.3% YoY) and net profit of ₹889 Cr (+6.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹889 Cr · +6.1% YoY
Other other announcement announcements
All →Kansai Nerolac Paints Other Announcement
Kansai Nerolac authorised Pravin Chaudhari, Yash Ahuja and Rukmini Subramanian to determine material events from 1 December 2026. It only lists KMP and contact details.
Glenmark Pharmaceuticals Other Announcement
Glenmark's partner IGI will present updated Phase 1 clinical data for ISB 2001 (ABBV-2001) in relapsed/refractory multiple myeloma at the 68th ASH Annual Meeting. The presentation is scheduled for December 12, 2026.
Vineet Laboratories Other Announcement
Vineet Laboratories' board appointed SVRL & Co. as statutory auditors, subject to shareholder approval. The five-year term runs from the 10th AGM to the 16th AGM.
Physicswallah Other Announcement
Physicswallah's IPO monitoring report flags a deviation from offer objects for the quarter ended September 30, 2026. The diverted funds were restored on October 30, 2026.
Gujarat Kidney and Super Speciality Other Announcement
Gujarat Kidney filed Brickwork's monitoring agency report for the quarter ended September 30, 2026. It confirms no deviation from the IPO fund-utilisation objects.
PDS Other Announcement
PDS Limited submitted the CRISIL Ratings monitoring agency report for the quarter ended September 30, 2026. It confirms no deviation in the utilisation of its QIP proceeds.